CPT 96372 was not among any revised or deleted codes Conversion Factor Change (Most Impactful): CMS established two separate conversion factors for CY 2026, the first time in Medicare history this has occurred Non-APM participants: $33.40 per RVU APM participants: $33.57 per RVU Source: CMS CY 2026 MPFS Final Rule Work RVU Efficiency Adjustment: A minus 2.5% efficiency adjustment applies to the work RVU component of established codes, including CPT 96372 This adjustment reduces the work RVU value used in the payment calculation CMS's stated rationale is that providers become more efficient over time with established procedures, reducing the relative work involved NCCI Version 32.0: NCCI Version 32.0 became effective January 1, 2026 Verify the current Procedure-to-Procedure (PTP) edit table for CPT 96372 against the January 2026 NCCI update before billing injection combinations Source: CMS NCCI Policy Manual CMS Transmittal 13673 (CR 14392): Implementation date: April 6, 2026 This transmittal updates the Medicare Physician Fee Schedule Database (MPFSDB) for the second quarterly update of 2026 Current pricing files are RVU26B and PFREV26B, last updated March 10, 2026 RCM teams must confirm their billing systems reflect the April 2026 quarterly files, not the January 2026 release Source: CMS Transmittal 13673 MUE Updates: CMS updates MUE limits quarterly

If we want to allow for these potentially miracle peptides to be available to the mainstream we must figure out a way to do it in a more responsible way
Another standout observation by the scientists was a potential rise in total pituitary RNA and GH mRNA due to CJC-1295, suggesting a possible increase in somatotroph cells - the pituitary gland cells believed to produce growth hormone
During protein folding stress, the sirtuin SIRT7 also plays an important role by contributing to repressing nuclear respiratory factor 1 (NRF1) activity, a major transcriptional regulator of mitochondrial genes
10.1089/ars.2016.6866 82 YuF.YuC.LiF.ZuoY.WangY.YaoL.et al (2021)
When it was applied to the skin or injected into the body, it sped up the skins ability to regrow by as much as 61% and helped the wound close about 11% more than in untreated animals